-transparent.png){kind=logo}
Concurrent administration of lithium (Li) significantly attenuates the dopamine (DA) depleting effects of reserpine and tetrabenazine, but does not change alpha-methyl-p-tyrosine (AMPT) induced DA depletion in rat brain. This effect of Li is probably mediated, in part, by inhibiting the magnesium-dependent binding of both reserpine and tetrabenazine to their specific receptor sites. Such interaction between these drugs may attenuate the beneficial effects of tetrabenazine and reserpine on patients with tardive dyskinesia or tardive dystonia who are treated concurrently with lithium for their psychiatric disorder.
Related Publications
A Reches, and
M N Hassan, and
V R Jackson, and
S Fahn
March 1973,
Psychopharmacologia,
A Reches, and
M N Hassan, and
V R Jackson, and
S Fahn
June 1996,
The Biochemical journal,
A Reches, and
M N Hassan, and
V R Jackson, and
S Fahn
January 1988,
Yao xue xue bao = Acta pharmaceutica Sinica,
A Reches, and
M N Hassan, and
V R Jackson, and
S Fahn
April 1974,
Psychopharmacologia,
A Reches, and
M N Hassan, and
V R Jackson, and
S Fahn
December 1983,
Japanese journal of pharmacology,
A Reches, and
M N Hassan, and
V R Jackson, and
S Fahn
December 1993,
Molecular and chemical neuropathology,
A Reches, and
M N Hassan, and
V R Jackson, and
S Fahn
August 1979,
Endocrinology,
A Reches, and
M N Hassan, and
V R Jackson, and
S Fahn
October 1973,
Psychopharmacologia,
A Reches, and
M N Hassan, and
V R Jackson, and
S Fahn
January 1973,
Polish journal of pharmacology and pharmacy,
A Reches, and
M N Hassan, and
V R Jackson, and
S Fahn
May 1977,
The Journal of pharmacology and experimental therapeutics,
